Exposure to select PFAS and PFAS mixtures alters response to platinum-based chemotherapy in endometrial cancer cell lines.
Environ Health.
2023 Dec 14;22(1):87. doi: 10.1186/s12940-023-01034-2. PubMed PMID:
38098045; PubMed Central PMCID:
PMC10720226.
Fluorescence-guided photoimmunotherapy using targeted nanotechnology and ML7710 to manage peritoneal carcinomatosis.
Sci Adv.
2023 Sep 8;9(36):eadi3441. doi: 10.1126/sciadv.adi3441. Epub 2023 Sep 6. PubMed PMID:
37672582; PubMed Central PMCID:
PMC10482332.
Transient fluid flow improves photoimmunoconjugate delivery and photoimmunotherapy efficacy.
iScience.
2023 Aug 18;26(8):107221. doi: 10.1016/j.isci.2023.107221. eCollection 2023 Aug 18. PubMed PMID:
37520715; PubMed Central PMCID:
PMC10372742.
Photochemical Targeting of Mitochondria to Overcome Chemoresistance in Ovarian Cancer (†).
Photochem Photobiol.
2023 Mar;99(2):448-468. doi: 10.1111/php.13723. Epub 2022 Oct 19. Review. PubMed PMID:
36117466; PubMed Central PMCID:
PMC10043796.
Photodynamic Priming Overcomes Per- and Polyfluoroalkyl Substance (PFAS)-Induced Platinum Resistance in Ovarian Cancer(†).
Photochem Photobiol.
2023 Mar;99(2):793-813. doi: 10.1111/php.13728. Epub 2022 Nov 7. PubMed PMID:
36148678; PubMed Central PMCID:
PMC10033467.
Photodynamic Stromal Depletion Enhances Therapeutic Nanoparticle Delivery in 3D Pancreatic Ductal Adenocarcinoma Tumor Models.
Photochem Photobiol.
2023 Jan;99(1):120-131. doi: 10.1111/php.13663. Epub 2022 Aug 3. PubMed PMID:
35699307; PubMed Central PMCID:
PMC10082669.
Water transport regulates nucleus volume, cell density, Young's modulus, and E-cadherin expression in tumor spheroids.
Eur J Cell Biol.
2022 Sep-Nov;101(4):151278. doi: 10.1016/j.ejcb.2022.151278. Epub 2022 Oct 21. PubMed PMID:
36306595.
Critical PDT theory II: Current concepts and indications.
Photodiagnosis Photodyn Ther.
2022 Sep;39:102923. doi: 10.1016/j.pdpdt.2022.102923. Epub 2022 May 21. PubMed PMID:
35605924; PubMed Central PMCID:
PMC9458629.
Select Per- and Polyfluoroalkyl Substances (PFAS) Induce Resistance to Carboplatin in Ovarian Cancer Cell Lines.
Int J Mol Sci.
2022 May 5;23(9). doi: 10.3390/ijms23095176. PubMed PMID:
35563566; PubMed Central PMCID:
PMC9104343.
Per- and poly-fluoroalkyl substances (PFAS) and female reproductive outcomes: PFAS elimination, endocrine-mediated effects, and disease.
Toxicology.
2022 Jan 15;465:153031. doi: 10.1016/j.tox.2021.153031. Epub 2021 Nov 10. Review. PubMed PMID:
34774661; PubMed Central PMCID:
PMC8743032.
Mechanical Modulation of Ovarian Cancer Tumor Nodules Under Flow.
IEEE Trans Biomed Eng.
2022 Jan;69(1):294-301. doi: 10.1109/TBME.2021.3092641. Epub 2021 Dec 23. PubMed PMID:
34170820; PubMed Central PMCID:
PMC8750319.
Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response.
Cancers (Basel).
2021 Aug 26;13(17). doi: 10.3390/cancers13174318. Review. PubMed PMID:
34503128; PubMed Central PMCID:
PMC8430600.
Emerging biofabrication approaches for gastrointestinal organoids towards patient specific cancer models.
Cancer Lett.
2021 Apr 28;504:116-124. doi: 10.1016/j.canlet.2021.01.023. Epub 2021 Feb 9. Review. PubMed PMID:
33577978.
Photodestruction of Stromal Fibroblasts Enhances Tumor Response to PDT in 3D Pancreatic Cancer Coculture Models.
Photochem Photobiol.
2021 Mar;97(2):416-426. doi: 10.1111/php.13339. Epub 2020 Oct 27. PubMed PMID:
33011973; PubMed Central PMCID:
PMC7965253.
Vitamin D Receptor Activation and Photodynamic Priming Enables Durable Low-dose Chemotherapy.
Mol Cancer Ther.
2020 Jun;19(6):1308-1319. doi: 10.1158/1535-7163.MCT-19-0791. Epub 2020 Mar 27. PubMed PMID:
32220968; PubMed Central PMCID:
PMC7272264.
Cabozantinib Inhibits Photodynamic Therapy-Induced Auto- and Paracrine MET Signaling in Heterotypic Pancreatic Microtumors.
Cancers (Basel).
2020 May 29;12(6). doi: 10.3390/cancers12061401. PubMed PMID:
32485915; PubMed Central PMCID:
PMC7352584.
Flow-induced Shear Stress Confers Resistance to Carboplatin in an Adherent Three-Dimensional Model for Ovarian Cancer: A Role for EGFR-Targeted Photoimmunotherapy Informed by Physical Stress.
J Clin Med.
2020 Mar 28;9(4). doi: 10.3390/jcm9040924. PubMed PMID:
32231055; PubMed Central PMCID:
PMC7230263.
Photodynamic Therapy and the Biophysics of the Tumor Microenvironment.
Photochem Photobiol.
2020 Mar;96(2):232-259. doi: 10.1111/php.13209. Epub 2020 Mar 5. Review. PubMed PMID:
31895481; PubMed Central PMCID:
PMC7138751.
Cancer Cell-targeted and Activatable Photoimmunotherapy Spares T Cells in a 3D Coculture Model.
Photochem Photobiol.
2020 Mar;96(2):295-300. doi: 10.1111/php.13153. Epub 2019 Oct 13. PubMed PMID:
31424560; PubMed Central PMCID:
PMC7028482.
Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D culture platform of pancreatic cancer.
Biomaterials.
2019 Nov;222:119421. doi: 10.1016/j.biomaterials.2019.119421. Epub 2019 Aug 12. PubMed PMID:
31494503; PubMed Central PMCID:
PMC6934357.
Mechanical Characterization of 3D Ovarian Cancer Nodules Using Brillouin Confocal Microscopy.
Cell Mol Bioeng.
2019 Jun;12(3):215-226. doi: 10.1007/s12195-019-00570-7. eCollection 2019 Jun. PubMed PMID:
31719911; PubMed Central PMCID:
PMC6816613.
Illuminating the Numbers: Integrating Mathematical Models to Optimize Photomedicine Dosimetry and Combination Therapies.
Front Phys.
2019 Apr;7. doi: 10.3389/fphy.2019.00046. Epub 2019 Apr 2. PubMed PMID:
31123672; PubMed Central PMCID:
PMC6529192.
A Combination of Visudyne and a Lipid-anchored Liposomal Formulation of Benzoporphyrin Derivative Enhances Photodynamic Therapy Efficacy in a 3D Model for Ovarian Cancer.
Photochem Photobiol.
2019 Jan;95(1):419-429. doi: 10.1111/php.13066. Epub 2019 Jan 7. PubMed PMID:
30499113; PubMed Central PMCID:
PMC7473467.
Photodynamic therapy: Promoting in vitro efficacy of photodynamic therapy by liposomal formulations of a photosensitizing agent.
Lasers Surg Med.
2018 Jul;50(5):499-505. doi: 10.1002/lsm.22813. Epub 2018 Mar 11. PubMed PMID:
29527710; PubMed Central PMCID:
PMC7449601.
Neoadjuvant photodynamic therapy augments immediate and prolonged oxaliplatin efficacy in metastatic pancreatic cancer organoids.
Oncotarget.
2018 Feb 27;9(16):13009-13022. doi: 10.18632/oncotarget.24425. eCollection 2018 Feb 27. PubMed PMID:
29560127; PubMed Central PMCID:
PMC5849191.
Mechanism-informed Repurposing of Minocycline Overcomes Resistance to Topoisomerase Inhibition for Peritoneal Carcinomatosis.
Mol Cancer Ther.
2018 Feb;17(2):508-520. doi: 10.1158/1535-7163.MCT-17-0568. Epub 2017 Nov 22. PubMed PMID:
29167313; PubMed Central PMCID:
PMC5805648.
Photodynamic Priming Mitigates Chemotherapeutic Selection Pressures and Improves Drug Delivery.
Cancer Res.
2018 Jan 15;78(2):558-571. doi: 10.1158/0008-5472.CAN-17-1700. Epub 2017 Nov 29. PubMed PMID:
29187403; PubMed Central PMCID:
PMC5771811.
Photodynamic Therapy Synergizes with Irinotecan to Overcome Compensatory Mechanisms and Improve Treatment Outcomes in Pancreatic Cancer.
Cancer Res.
2016 Mar 1;76(5):1066-77. doi: 10.1158/0008-5472.CAN-15-0391. Epub 2015 Dec 30. PubMed PMID:
26719532; PubMed Central PMCID:
PMC4775276.
The role of photodynamic therapy in overcoming cancer drug resistance.
Photochem Photobiol Sci.
2015 Aug;14(8):1476-91. doi: 10.1039/c4pp00495g. Epub 2015 Apr 9. Review. PubMed PMID:
25856800; PubMed Central PMCID:
PMC4520758.
Low-cost photodynamic therapy devices for global health settings: Characterization of battery-powered LED performance and smartphone imaging in 3D tumor models.
Sci Rep.
2015 May 12;5:10093. doi: 10.1038/srep10093. PubMed PMID:
25965295; PubMed Central PMCID:
PMC4428052.
In vivo evaluation of battery-operated light-emitting diode-based photodynamic therapy efficacy using tumor volume and biomarker expression as endpoints.
J Biomed Opt.
2015 Apr;20(4):048003. doi: 10.1117/1.JBO.20.4.048003. PubMed PMID:
25909707; PubMed Central PMCID:
PMC4408448.
"Pointsource" delivery of a photosensitizer drug and singlet oxygen: eradication of glioma cells in vitro.
Photochem Photobiol.
2014 Sep-Oct;90(5):1119-25. doi: 10.1111/php.12274. Epub 2014 Apr 21. PubMed PMID:
24673689; PubMed Central PMCID:
PMC4198175.
Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates.
Proc Natl Acad Sci U S A.
2014 Mar 11;111(10):E933-42. doi: 10.1073/pnas.1319493111. Epub 2014 Feb 26. PubMed PMID:
24572574; PubMed Central PMCID:
PMC3956156.
An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models.
Sci Rep.
2014 Jan 17;4:3751. doi: 10.1038/srep03751. PubMed PMID:
24435043; PubMed Central PMCID:
PMC3894557.
Impact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer.
J Biomed Opt.
2013 Sep;18(9):098004. doi: 10.1117/1.JBO.18.9.098004. PubMed PMID:
24802230; PubMed Central PMCID:
PMC3783041.
PDT dose parameters impact tumoricidal durability and cell death pathways in a 3D ovarian cancer model.
Photochem Photobiol.
2013 Jul-Aug;89(4):942-52. doi: 10.1111/php.12065. Epub 2013 Apr 4. PubMed PMID:
23442192; PubMed Central PMCID:
PMC3701746.
Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules.
Proc Natl Acad Sci U S A.
2013 May 28;110(22):E1974-83. doi: 10.1073/pnas.1216989110. Epub 2013 May 3. PubMed PMID:
23645635; PubMed Central PMCID:
PMC3670329.
Image-Based Quantification of Benzoporphyrin Derivative Uptake, Localization, and Photobleaching in 3D Tumor Models, for Optimization of PDT Parameters.
Theranostics.
2012;2(9):827-39. doi: 10.7150/thno.4334. Epub 2012 Sep 5. PubMed PMID:
23082096; PubMed Central PMCID:
PMC3475211.
Photoimmunotherapy and irradiance modulation reduce chemotherapy cycles and toxicity in a murine model for ovarian carcinomatosis: perspective and results.
Isr J Chem.
2012 Sep;52(8-9):776-787. doi: 10.1002/ijch.201200016. PubMed PMID:
23626376; PubMed Central PMCID:
PMC3634612.
Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT.
PLoS One.
2011;6(8):e23434. doi: 10.1371/journal.pone.0023434. Epub 2011 Aug 18. PubMed PMID:
21876751; PubMed Central PMCID:
PMC3158086.
A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform.
Biotechnol J.
2011 Feb;6(2):204-212. doi: 10.1002/biot.201000340. PubMed PMID:
21298805; PubMed Central PMCID:
PMC3780785.
Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer.
Cancer Res.
2010 Nov 15;70(22):9234-42. doi: 10.1158/0008-5472.CAN-10-1190. Epub 2010 Nov 2. PubMed PMID:
21045152; PubMed Central PMCID:
PMC3057762.
Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer.
Cancer Res.
2010 Nov 15;70(22):9319-28. doi: 10.1158/0008-5472.CAN-10-1783. Epub 2010 Nov 9. PubMed PMID:
21062986; PubMed Central PMCID:
PMC3057933.
Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model.
J Biomed Opt.
2010 Sep-Oct;15(5):051603. doi: 10.1117/1.3483903. PubMed PMID:
21054077; PubMed Central PMCID:
PMC2948043.
Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.
Chem Rev.
2010 May 12;110(5):2795-838. doi: 10.1021/cr900300p. Review. PubMed PMID:
20353192; PubMed Central PMCID:
PMC2896821.
Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models.
Int J Radiat Oncol Biol Phys.
2010 Jan 1;76(1):251-9. doi: 10.1016/j.ijrobp.2009.08.041. PubMed PMID:
20005458; PubMed Central PMCID:
PMC2902770.
PuraMatrix encapsulation of cancer cells.
J Vis Exp.
2009 Dec 17;(34). doi: 10.3791/1692. PubMed PMID:
20019656; PubMed Central PMCID:
PMC3152243.
In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring.
Br J Cancer.
2009 Dec 15;101(12):2015-22. doi: 10.1038/sj.bjc.6605436. Epub 2009 Nov 17. PubMed PMID:
19920823; PubMed Central PMCID:
PMC2795438.
In vitro ovarian tumor growth and treatment response dynamics visualized with time-lapse OCT imaging.
Opt Express.
2009 May 25;17(11):8892-906. doi: 10.1364/oe.17.008892. PubMed PMID:
19466138; PubMed Central PMCID:
PMC2836890.
In-vivo singlet oxygen dosimetry of clinical 5-aminolevulinic acid photodynamic therapy.
J Biomed Opt.
2008 Sep-Oct;13(5):050504. doi: 10.1117/1.2981813. PubMed PMID:
19021376; PubMed Central PMCID:
PMC2994192.
What would you like to do?